These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 709539)

  • 1. Value of serum copper levels and erythrocyte sedimentation rates as indicators of disease activity in children with Hodgkin's disease.
    Wilimas J; Thompson E; Smith KL
    Cancer; 1978 Oct; 42(4):1929-35. PubMed ID: 709539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum copper compared to erythrocyte sedimentation rate as indicator of disease activity in Hodgkin's disease.
    Asbjörnsen G
    Scand J Haematol; 1979 Mar; 22(3):193-6. PubMed ID: 451449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum copper, serum ceruloplasmin, and erythrocyte sedimentation rate measurements in children with Hodgkin's disease, non-Hodgkin's lymphoma, and nonmalignant lymphadenopathy.
    Margerison AC; Mann JR
    Cancer; 1985 Apr; 55(7):1501-6. PubMed ID: 3978543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum copper in Hodgkin's disease in children.
    Tessmer CF; Hrgovcic M; Wilbur J
    Cancer; 1973 Feb; 31(2):303-15. PubMed ID: 4687877
    [No Abstract]   [Full Text] [Related]  

  • 5. The value of serum copper levels in non-Hodgkin's lymphoma.
    Cohen Y; Epelbaum R; Haim N; McShan D; Zinder O
    Cancer; 1984 Jan; 53(2):296-300. PubMed ID: 6690011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
    Bien E; Balcerska A
    Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of erythrocyte sedimentation rate, C-reactive protein and serum lactate dehydrogenase levels in the diagnosis, prognosis and treatment monitoring of children suffering from cancer].
    Bień E; Balcerska A
    Med Wieku Rozwoj; 2004; 8(4 Pt 2):1081-9. PubMed ID: 15951603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum alpha-1-acid-glycoprotein, haptoglobin and C3 in Hodgkin's disease. A comparison with other acute-phase indicators.
    Gobbi PG; Merlini G; Parrinello GA; Cavalli P; Ascari E
    Acta Haematol; 1982; 67(4):255-62. PubMed ID: 6180585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte sedimentation rate predicts early relapse and survival in early-stage Hodgkin disease. The EORTC Lymphoma Cooperative Group.
    Henry-Amar M; Friedman S; Hayat M; Somers R; Meerwaldt JH; Carde P; Burgers JM; Thomas J; Monconduit M; Noordijk EM
    Ann Intern Med; 1991 Mar; 114(5):361-5. PubMed ID: 1992877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceruloplasmin in Hodgkin's disease.
    Koprivová H; Dienstbier Z; Sámal M; Foltýnová V
    Neoplasma; 1982; 29(3):333-40. PubMed ID: 7133228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of laboratory indicators in Hodgkin's disease: preliminary results.
    Ray GR; Wolf PH; Kaplan HS
    Natl Cancer Inst Monogr; 1973 May; 36():315-23. PubMed ID: 4744591
    [No Abstract]   [Full Text] [Related]  

  • 12. The clinical usefulness of serum copper determinations in Hodgkin's disease. A retrospective study of 241 patients from 1963-1973.
    Thorling EB; Thorling K
    Cancer; 1976 Jul; 38(1):225-31. PubMed ID: 947517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of erythrocyte sedimentation rate as predictor of early relapse in posttherapy early-stage Hodgkin's disease.
    Friedman S; Henry-Amar M; Cosset JM; Carde P; Hayat M; Dupouy N; Tubiana M
    J Clin Oncol; 1988 Apr; 6(4):596-602. PubMed ID: 3357004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of erythrocyte sedimentation rate in clinical stages I-II of Hodgkin's disease.
    Tubiana M; Henry-Amar M; Burgers MV; van der Werf-Messing B; Hayat M
    J Clin Oncol; 1984 Mar; 2(3):194-200. PubMed ID: 6366151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on serum copper and zinc levels and copper/zinc ratio in malignant lymphoma].
    Wu HY
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):335-8. PubMed ID: 3248498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic markers of disease activity in Hodgkin's disease.
    Martinow AJ; Yuen K; Cooper IA; Matthews JP; Juneja S; Wolf M; Januszewicz H; Prince HM
    Leuk Lymphoma; 1998 Apr; 29(3-4):383-9. PubMed ID: 9684935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum copper levels in adult patients with Hodgkin's disease.
    Hrgovcic M; Tessmer CF; Thomas FB; Fuller LM; Gamble JF; Shullenberger CC
    Cancer; 1973 Jun; 31(6):1337-45. PubMed ID: 4709950
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of metabolic parameters in Hodgkin's disease (author's transl)].
    Oertel J; Gerhartz H
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Jun; 86(2):185-93. PubMed ID: 59479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of copper level in serum and routine laboratory parameters in estimation of outspreading of Hodgkin's lymphoma.
    Jamakovic M; Baljic R
    Med Arch; 2013; 67(3):185-7. PubMed ID: 23848039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum trace elements and Cu/Zn ratio in malignant lymphomas in children.
    Gupta SK; Shukla VK; Gupta V; Gupta S
    J Trop Pediatr; 1994 Jun; 40(3):185-7. PubMed ID: 8078119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.